May 18, 2023
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
Financing accelerates MT-302, the Company’s first clinical candidate for in vivo cell programming, into a Phase 1/2 clinical trial for TROP2+ solid tumors CAMBRIDGE, Mass., May 18, 2023 – Myeloid…
May 3, 2023
NewYork-Presbyterian Enrolls First Patient in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease
For Marco B. Zoccali, MD, FACS, a colorectal surgeon at NewYork-Presbyterian/Columbia, sacral nerve stimulation (SNS) has been a routine part of the care he provides to his patients with fecal incontinence.…
April 3, 2023
It is with the heaviest of hearts that we mourn the passing of our partner, mentor, and friend – Robert A. Ingram
Bob was the most giving of people, who always had the time and focus to make you feel like you were his only concern. As the leader of GlaxoWellcome, he…
December 8, 2022
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series…
September 19, 2022
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery Signs Definitive Agreement to Acquire Standard Bariatrics WAYNE, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) --…
May 11, 2022
They’re Back – Will We See the M&A Boon? Hatteras White Paper on Biotech M&A
By: Clay Thorp, General Partner, Hatteras Venture Partners Michael Yee of Jefferies is one of the best analysts in biotech, and he knows his stuff. Yee recently wrote a…
April 25, 2022
Qvella FAST System and FAST-PBC Prep Cartridge Get CE Marked and FDA Listed for In Vitro Diagnostic Use
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods TORONTO & LISBON,…
February 7, 2022
Huma.AI Adds Post-Market Surveillance Capacity to its Unique AI-Based Healthcare Data Knowledge Platform
Company also secures $9.5 million in Series A funding to expand its resources to meet rapidly growing customer demand PALO ALTO, Calif.--(BUSINESS WIRE)--Huma.AI has expanded its self-service business intelligence platform…
January 25, 2022
Aledade Acquires Advance Care Planning Company Iris Healthcare as Part of New Health Services Arm
Acquisition Enables Company to Provide More High-Value, Patient-Centered Services Through Its Network of More Than 1,000 Independent Primary Care Practices and Health Centers Bethesda, Md. -- January 11, 2022 -- Aledade,…
January 7, 2022
VIGIL NEUROSCIENCE ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,…